Full-Time

Risk Division-Associate

Confirmed live in the last 24 hours

Goldman Sachs

Goldman Sachs

Global investment banking and asset management firm

No salary listed

Junior, Mid

Company Historically Provides H1B Sponsorship

Dallas, TX, USA

Category
Risk Management
Finance & Banking
Required Skills
Financial analysis
Requirements
  • Bachelor’s degree (U.S. or foreign equivalent) in Economics, Accounting, Business Administration or related field
  • Two (2) years of experience in the job offered or in a related role
  • Fluency in Portuguese is required to communicate with Brazilian clients
  • Experience with applying concepts of credit risk and its components, including default risk, loss severity in the event of default and associated recovery rates
  • Experience evaluating factors required for assigning a credit rating and assessing company’s ability to make timely payments of interest and to repay debt
  • Experience conducting comprehensive credit risk assessments to evaluate the creditworthiness of borrowers, counterparties, and financial instruments for Latin American clients
  • Experience reviewing financial statements, company presentations and market reports for companies in Brazil and other parts of Latin America
  • Experience assessing a company’s operating performance, capital structure, cash flow generation and consumption trends and financial prospects
  • Experience applying tools and techniques used in financial analysis, noting their uses and limitations and calculating and interpreting liquidity, solvency, leverage, and profitability ratios
  • Experience adjusting ratios for Latin American clients in line with local accounting practices
  • Experience developing and implementing credit risk management strategies, policies, and procedures
  • Experience assessing credit risk models and methodologies
  • Experience navigating through the Federal Reserve Bank Shared National Credit (“SNC”) program
  • Experience examining Commitment Papers and Credit Agreements
Responsibilities
  • Assess the credit and financial strength of the firm's borrowers and counterparts across North American Natural Resource counterparties and Latin American counterparties by performing fundamental credit analysis using both quantitative and qualitative factors
  • Review and approve loan transactions, determine appetite and regulatory ratings, monitor credit trends in the portfolio
  • Analyze the credit implications of various financial transactions including debt, equity and hybrid offerings, mergers and acquisitions, restructuring and share repurchases
  • Coordinate with Global Banking and Markets (GBM), Legal, Operations and Compliance departments to approve derivatives business and ensure appropriate documentation, limits, and risk mitigants to protect against a counterpart default and minimize potential losses
  • Analyze the risks inherent in the products GS transacts, including lending, trading, and derivative products
  • Perform sector analysis regularly in order to assess portfolio concentration or trends
  • Monitor, manage and report exposures at a counterpart, product, and portfolio level

Goldman Sachs provides a variety of financial services, including investment banking, asset management, and securities trading. The firm offers advisory services for mergers and acquisitions, helps clients with underwriting securities, and manages assets for a diverse clientele that includes corporations, financial institutions, governments, and wealthy individuals. Revenue is earned through fees for these advisory services, trading commissions, and asset management fees. Goldman Sachs distinguishes itself from competitors by its extensive experience and commitment to social responsibility, which includes initiatives to support small businesses and promote racial equity.

Company Size

N/A

Company Stage

IPO

Headquarters

New York City, New York

Founded

1869

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased focus on AI-driven platforms enhances Goldman Sachs' data extraction and valuation capabilities.
  • Goldman Sachs' investment in digital nutritional therapy aligns with growing health-focused financial markets.
  • Involvement in urban infrastructure projects boosts Goldman Sachs' brand in sustainable investments.

What critics are saying

  • AI-driven platforms like 73 Strings could disrupt traditional investment management services.
  • Potential overexposure to high-risk investments in emerging sectors like digital nutritional therapy.
  • Regulatory scrutiny from investments in controversial sectors like stormwater infrastructure.

What makes Goldman Sachs unique

  • Goldman Sachs excels in diverse financial services, including investment banking and asset management.
  • The firm is committed to social responsibility, supporting small businesses and racial equity.
  • Goldman Sachs has a strong global presence, serving corporations, governments, and high-net-worth individuals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Professional Development Budget

Company News

PR Newswire
Mar 4th, 2025
Mews Secures Major Investment to Cement Industry Leadership and Redefine Hospitality Management

/PRNewswire/ -- Mews, the leading hospitality technology platform, today announced it has raised $75 million, led by Tiger Global, a leading global investment...

Business Wire
Feb 20th, 2025
73 Strings Secures $55m Series B Led by Growth Equity at Goldman Sachs Alternatives

73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Altern

Business Wire
Feb 15th, 2025
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 mil

Business Wire
Feb 14th, 2025
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines

Newleos Therapeutics, Inc., a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, today anno

Tines
Feb 11th, 2025
Announcing our $125M Series C fundraise | Tines

Learn how we’re accelerating investments in product innovation, world-class support, value-adding AI features, and enhanced security capabilities.